Handel nachbörslich: 6.68

Neuropace Inc (NPCE)

Neuropace Inc Aktie (NPCE) Neueste Nachrichten

Neuropace Inc (NPCE)

Neuropace Inc Aktie (NPCE) Neueste Nachrichten

BCI and EEG Market Future Developments, Upcoming Trends, and Top-Vendor Landscape 2020 to 2032 Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc – Cauverynews - Cauverynews

National Bank of Canada (OTCMKTS:NTIOF) Hits New 1-Year High at $94.20 - Defense World

Understanding the Risks of Investing in Noble Corp Plc (NE) - Knox Daily

Nothing is Better Than New Found Gold Corp (NFGC) stock at the moment - SETE News

Avoro Capital Advisors LLC Makes New Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Navratna PSU stock rises on Rs 1,261-crore order from health ministry - Business Today

One Point One Solutions shares gain as company expands healthcare verticalCheck details - MSN

NEPSE index up by 11.58 points - The Himalayan Times

Nb bancorp director buys $1,862 in company stock By Investing.com - Investing.com UK

Acadian Asset Management LLC Has $520,000 Position in NeuroPace, Inc. (NASDAQ:NPCE) - Defense World

Nampo Cape 2024 attracts 45 894 visitors, 10 000 visitors more than last year’s - Farmers Review Africa

Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling - Business Wire

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World

Carlyle Group Revives IPO for Nouryon: Private Equity Giant Eyes Big Move in Specialty Chemicals - Share Price India News

BCI and EEG Market 2031 Growth Drivers along with Top Players- Nihon Kohden, Natus Medical, Medtronic, NeuroPace Inc, Mindmaze SA, Brai – news - meramandsaur.in

NeuroPace, Inc. (NASDAQ:NPCE) Receives $14.00 Consensus Target Price from Analysts - MarketBeat

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Vagus Nerve Stimulators Market Report, Size, Share & Outlook - openPR

NeuroPace makes two key leadership appointments - Medical Buyer

Microelectronic Medical Implants Market Report 2024-2029, with Profiles of Leading Players, including Abbott, Biotronik, Cochlear, LivaNova, Medtronic, Neuropace and Nevro - Yahoo Finance UK

NeuroPace names new vice presidents for R&D and marketing - Investing.com

NeuroPace names new vice presidents for R&D and marketing - Investing.com India

NeuroPace Strengthens Management Team with Two Key Appointments - ForexTV.com

NeuroPace Strengthens Management Team with Two Key Appointments - StockTitan

Bioelectric Medicine Market Dazzling Worldwide | Major Giants Medtronic, Abbott, NeuroPace - Daily News Mirror

Neurostimulation Devices Market to Witness Huge Growth by 2031 - openPR

NeuroPace, Inc. (NASDAQ:NPCE) Shares Bought by Financial Advocates Investment Management - Defense World

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences - StockTitan

NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up - MSN

NeuroPace to Participate in Upcoming Healthcare Conferences in September - StockTitan

NPCENeuroPace, Inc. Latest Stock News & Market Updates - StockTitan

NeuroPace: Only For Those With Strong Nerves (NASDAQ:NPCE) - Seeking Alpha

NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up - Yahoo Finance

NeuroPace Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

FY2024 EPS Estimates for NeuroPace, Inc. (NASDAQ:NPCE) Increased by Analyst - MarketBeat

Research Analysts Set Expectations for NeuroPace, Inc.’s FY2024 Earnings (NASDAQ:NPCE) - Defense World

NeuroPace (NASDAQ:NPCE) Price Target Cut to $15.00 by Analysts at Wells Fargo & Company - Defense World

Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Price Target at $14.00 - MarketBeat

NeuroPace’s (NPCE) Overweight Rating Reiterated at Cantor Fitzgerald - Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Position Raised by Vanguard Group Inc. - Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Shares Purchased by Vanguard Group Inc. - MarketBeat

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Leerink Partnrs Research Analysts Boost Earnings Estimates for NeuroPace, Inc. (NASDAQ:NPCE) - MarketBeat

Q3 2024 Earnings Estimate for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - Defense World

Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57 - Yahoo Finance

Selling Buzz: NeuroPace Inc [NPCE] 10% Owner ORBIMED ADVISORS LLC sells 15,690 shares of the company - Knox Daily

NeuroPace Inc (NPCE) Stock: A Year of Market Fluctuations - The InvestChronicle

NeuroPace, Inc. (NASDAQ:NPCE) Q2 2024 Earnings Call Transcript - Insider Monkey

NeuroPace (NASDAQ:NPCE) Issues Earnings Results, Beats Estimates By $0.03 EPS - Defense World

NeuroPace shares target cut by Wolfe Research - Investing.com

Earnings call: NeuroPace sees 17% revenue jump in Q2, RNS system drives growth - Investing.com

Earnings call: NeuroPace sees 17% revenue jump in Q2, RNS system drives growth - Investing.com India

Earnings call: NeuroPace sees 17% revenue jump in Q2, RNS system drives growth - Investing.com UK

NeuroPace (NASDAQ:NPCE) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat

NeuroPace shares target cut by Wolfe Research - Investing.com Canada

Cantor Fitzgerald Reiterates Overweight Rating for NeuroPace (NASDAQ:NPCE) - MarketBeat

NeuroPace shares target cut by Wolfe Research - Investing.com India

NeuroPace shares target cut by Wolfe Research - Investing.com UK

NeuroPace’s revenue jumps 17% to USD 19.3M in Q2 2024 - Medical Buyer

Microelectronic Medical Implants Market Report 2024-2029, with Profiles of Leading Players, including - Daily Guardian Canada

Microelectronic Medical Implants Market Report 2024-2029, - GlobeNewswire

Microelectronic Medical Implants Market Report 2024-2029, with Profiles of Leading Players, including Abbott, Biotronik, Cochlear, LivaNova, Medtronic, Neuropace and Nevro - Yahoo Finance

Learn to Evaluate (NPCE) using the Charts - Stock Traders Daily

Ähnlich wie NPCE